Why the study?
The influence of specific dietary components, their mechanisms, and strategies to mitigate cancer-associated venous thromboembolism remain poorly investigated, despite population studies linking protein-rich diets with venous thromboembolism.
Does a high-protein or high-tryptophan diet increase cancer-associated venous thrombogenicity in colon cancer mouse models, and can this prothrombotic effect be mitigated by indoleamine 2,3-dioxygenase 1 (IDO1) inhibition?
Does a high-protein or high-tryptophan diet increase cancer-associated venous thrombogenicity in colon cancer mouse models, and can this prothrombotic effect be mitigated by indoleamine 2,3-dioxygenase 1 (IDO1) inhibition?
Dietary tryptophan promotes cancer-associated venous thrombosis via IDO1-mediated kynurenine production and endothelial procoagulant upregulation in colon cancer mouse models, an effect significantly attenuated by pharmacological IDO1 inhibition.
Answers are grounded in this paper and cite their sources.
High-protein diets may heighten VTE risk in cancer; animal findings leave open dietary or IDO1-targeted interventions for trials.
Studies related to cardio-oncology remain a high priority, considering that venous thromboembolism (VTE) in cancer survivors is the second most common cause of death. Although diet-derived metabolites are emerging as contributors to VTE, the influence of specific dietary components, their underlying mechanisms, and means to mitigate cancer-associated VTE remain poorly investigated. This point is important because population studies point to a protein-rich diet associated with VTE. Leveraging a new colon cancer-VTE mouse model, we show that an imbalanced protein-rich diet augments venous thrombogenicity in tumor-bearing mice. Further probing showed that dietary tryptophan induces a procoagulant venous wall, characterized by upregulation of tissue factor, plasminogen activator inhibitor-1, and von Willebrand factor and downregulation of thrombomodulin. Targeted metabolomics of sera from tumor-bearing mice revealed a pattern consistent with increased biogenesis of kynurenine (Kyn) and its suppressed catabolism, despite equal diet consumption in all groups. Kyn levels positively correlated with venous clots. Indoleamine 2,3-dioxygenase 1 (IDO1) is a key rate-limiting enzyme converting tryptophan to Kyn. Sera and the inferior vena cava of tumor-bearing mice showed greater IDO1 activity and protein level, respectively. A specific IDO1 inhibitor reduced serum levels of Kyn, restored the balance of procoagulant and anticoagulant factors in the venous endothelium, and significantly suppressed venous thrombogenicity in tumor-bearing mice. Taken together, our results uncovered a prothrombotic effect of a protein- or tryptophan-rich diet in a syngeneic colon cancer model, which is significantly attenuated by an IDO1 inhibitor.
No takes yet. Share an insight, caveat, or question.
Lotfollahzadeh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: